Clinical Diagnosis and Treatment of Primary Laryngeal Neuroendocrine Carcinoma
Ear, Nose & Throat Journal · 2025
DOI: 10.1177/01455613231155853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ear, Nose & Throat Journal, 2025. Verfasst von Yu Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, Dalian municipal Central Hospital, Dalian, China. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
This study aims to investigate the clinical diagnosis and treatment characteristics of primary laryngeal neuroendocrine carcinoma. Patients and Methods A retrospective analysis was performed for the data of 6 patients with primary laryngeal neuroendocrine carcinoma admitted to the Department of Otorhinolaryngology of Dalian Central Hospital from September 2015 to January 2022, all of whom were male patients. And laryngoscopy showed that 4 had a similar appearance to hemangioma, 1 had nodular hyperplasia, and 1 was papilloma-like. The site of onset was located on the laryngeal surface of the epiglottis in 3 cases, situated in the aryepiglottic fold in 2 cases, and the posterior ventricular zone in 1 case. Five patients underwent surgery, including 4 by transoral endoscopic cryogenic plasma radiofrequency mass resection; one underwent a cervical lymph node dissection and supraglottic horizontal hemilaryngectomy. The remaining 1 case was treated in another hospital after the pathological diagnosis was confirmed by biopsy. All patients had no cervical lymph node metastases and were not supplemented with chemoradiotherapy.
Results
The postoperative pathological diagnosis of all 5 patients was neuroendocrine carcinoma. No cancer cells were seen at the margins and base. One patient was lost to follow-up after treatment in another hospitals and the rest were followed up for 6 months to 6 years. One patient had removed laryngeal tumor and epiglottis by a low-temperature plasma radiofrequency ablation, recurrence 1 year after surgery, and no recurrence for 5 years after supraglottic horizontal hemilaryngectomy combined with prophylactic cervical lymph node dissection, no recurrence for the other 4 patients after 6 months to 4 years of follow-up.
Conclusion
The common sites of laryngeal neuroendocrine carcinoma are the laryngeal surface of the epiglottis and the aryepiglottic fold. The appearance of the tumor is mainly similar to that of hemangioma. Moreover, a common pathological classification is atypical carcinoid tumors, where early detection and surgical treatment can achieve a good therapeutic effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology Head and Neck Surgery, Dalian municipal Central Hospital, Dalian, China.
- Graduate School of Dalian Medical University, Dalian, China.
ORCID-Profile: Cuiping She
Zitieren
APA
Wang, Y., Liu, D., & She, C. (2025). Clinical Diagnosis and Treatment of Primary Laryngeal Neuroendocrine Carcinoma. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613231155853
Vancouver
Wang Y, Liu D, She C. Clinical Diagnosis and Treatment of Primary Laryngeal Neuroendocrine Carcinoma. Ear, Nose & Throat Journal. 2025. doi:10.1177/01455613231155853
BibTeX
@article{Wang2025,
author = {Wang, Yu and Liu, Delong and She, Cuiping},
title = {Clinical Diagnosis and Treatment of Primary Laryngeal Neuroendocrine Carcinoma},
journal = {Ear, Nose & Throat Journal},
year = {2025},
doi = {10.1177/01455613231155853}
}
EUVIMED